🇺🇸 FDA
Patent

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7405302 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by AMIRA PHARMACEUTICALS, INC. expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P11/08